Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Leases (2016 - 2025)

Historic Current Leases for Outlook Therapeutics (OTLK) over the last 8 years, with Q4 2025 value amounting to $61125.0.

  • Outlook Therapeutics' Current Leases rose 1610.79% to $61125.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $61125.0, marking a year-over-year increase of 1610.79%. This contributed to the annual value of $58897.0 for FY2025, which is N/A changed from last year.
  • Latest data reveals that Outlook Therapeutics reported Current Leases of $61125.0 as of Q4 2025, which was up 1610.79% from $58897.0 recorded in Q3 2025.
  • Outlook Therapeutics' Current Leases' 5-year high stood at $61125.0 during Q4 2025, with a 5-year trough of $52645.0 in Q4 2024.